BioCentury | Apr 10, 2020
Politics, Policy & Law

Piloting a new course to reimbursing antibiotics

...Kevin Outterson, executive director of the non-profit antibiotics accelerator CARB-X and professor of law at Boston University...
BioCentury | Jan 29, 2020
Politics & Policy

Harvard chemistry chair arrested, accused of lying about China ties

...charged with conducting research and sending U.S. documents and information to China while studying in Boston University’s...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...organs with machine learning In a paper published in Cell Systems , Gladstone Institutes and Boston University...
...Tumor necrosis factor receptor superfamily member 11b BioCentury Staff Excision BioTherapeutics Inc. Caribou Biosciences Inc. Kymab Group Ltd. Gladstone Institutes Boston University CRISPR-associated...
BioCentury | Jun 18, 2019
Distillery Therapeutics

RLN2 injections to treat shoulder arthrofibrosis

...same affiliation as above email: anazaria@bidmc.harvard.edu CONTACT: Mark W. Grinstaff, Boston University, Boston, Mass. email: mgrin@bu.edu Claire Quang Boston University Harvard...
BioCentury | Apr 23, 2019
Translation in Brief

J&J and Boston University identify classifications to catch lung cancer

...J&J and Boston University identified a subtype of precancerous lesions with genomic alterations and immune cell deficiencies...
...five-year collaboration the Johnson & Johnson Innovation LLC unit of Johnson & Johnson (NYSE:JNJ) and Boston University...
...Solutions in Shanghai" ). Author Avrum Spira, a professor of medicine, pathology and bioinformatics at Boston University...
BioCentury | Apr 4, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2019

...ZDHHC13 or inhibiting LYPLA2 could help treat melanoma University of Oxford ; Shandong University ; Boston University...
BioCentury | Mar 5, 2019
Distillery Therapeutics

MC1R, ZDHHC13 and LYPLA2 as new targets for melanoma

...Shandong, China email: junzhou@sdnu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...Fujian, China email: xmdeng@xmu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University...
BioCentury | Feb 5, 2019
Company News

Management tracks: Amazon-Berkshire Hathaway-JPM venture hires Kutan as CTO

...Mass.) hired Peter Weber as CMO, succeeding Leslie Shinobu. Weber is head of otology/neurotology at Boston University...
BioCentury | Jan 8, 2019
Distillery Therapeutics

Infectious disease

...FDA), Silver Spring, Md. email: tony.wang@fda.hhs.gov CONTACT: John A. Porco, Boston University, Boston, Mass. email: porco@bu.edu Claire Quang Boston University U.S...
Items per page:
1 - 10 of 239
BioCentury | Apr 10, 2020
Politics, Policy & Law

Piloting a new course to reimbursing antibiotics

...Kevin Outterson, executive director of the non-profit antibiotics accelerator CARB-X and professor of law at Boston University...
BioCentury | Jan 29, 2020
Politics & Policy

Harvard chemistry chair arrested, accused of lying about China ties

...charged with conducting research and sending U.S. documents and information to China while studying in Boston University’s...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...organs with machine learning In a paper published in Cell Systems , Gladstone Institutes and Boston University...
...Tumor necrosis factor receptor superfamily member 11b BioCentury Staff Excision BioTherapeutics Inc. Caribou Biosciences Inc. Kymab Group Ltd. Gladstone Institutes Boston University CRISPR-associated...
BioCentury | Jun 18, 2019
Distillery Therapeutics

RLN2 injections to treat shoulder arthrofibrosis

...same affiliation as above email: anazaria@bidmc.harvard.edu CONTACT: Mark W. Grinstaff, Boston University, Boston, Mass. email: mgrin@bu.edu Claire Quang Boston University Harvard...
BioCentury | Apr 23, 2019
Translation in Brief

J&J and Boston University identify classifications to catch lung cancer

...J&J and Boston University identified a subtype of precancerous lesions with genomic alterations and immune cell deficiencies...
...five-year collaboration the Johnson & Johnson Innovation LLC unit of Johnson & Johnson (NYSE:JNJ) and Boston University...
...Solutions in Shanghai" ). Author Avrum Spira, a professor of medicine, pathology and bioinformatics at Boston University...
BioCentury | Apr 4, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: March 2019

...ZDHHC13 or inhibiting LYPLA2 could help treat melanoma University of Oxford ; Shandong University ; Boston University...
BioCentury | Mar 5, 2019
Distillery Therapeutics

MC1R, ZDHHC13 and LYPLA2 as new targets for melanoma

...Shandong, China email: junzhou@sdnu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...Fujian, China email: xmdeng@xmu.edu.cn CONTACT: Rutao Cui, Boston University School of Medicine, Boston, Mass. email: rutaocui@bu.edu Claire Quang Boston University...
BioCentury | Feb 5, 2019
Company News

Management tracks: Amazon-Berkshire Hathaway-JPM venture hires Kutan as CTO

...Mass.) hired Peter Weber as CMO, succeeding Leslie Shinobu. Weber is head of otology/neurotology at Boston University...
BioCentury | Jan 8, 2019
Distillery Therapeutics

Infectious disease

...FDA), Silver Spring, Md. email: tony.wang@fda.hhs.gov CONTACT: John A. Porco, Boston University, Boston, Mass. email: porco@bu.edu Claire Quang Boston University U.S...
Items per page:
1 - 10 of 239